Literature DB >> 19026746

Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model.

Ryoichi Kimura1, Masuo Ohno.   

Abstract

Although animal models of Alzheimer's disease (AD) recapitulate beta-amyloid-dependent hippocampal synaptic and cognitive dysfunctions, it is poorly understood how cortex-dependent remote memory stabilization following initial hippocampal coding is affected. Here, we systematically analyzed biophysical and behavioral phenotypes, including remote memory functions, of 5XFAD APP/PS1 transgenic mice containing five familial AD mutations. We found that 5XFAD mice show hippocampal dysfunctions as observed by reduced levels of baseline transmission and long-term potentiation at Schaffer collateral-CA1 synapses. Hippocampus-dependent memory tested 1 day after contextual fear conditioning was also impaired age-dependently in 5XFAD mice, as correlated with the onset of hippocampal synaptic failures. Importantly, remote memory stabilization during 30 days after training significantly declined in 5XFAD mice at time well before the onset of hippocampal dysfunctions. Our results indicate that 5XFAD mice provide a useful model system to investigate the mechanisms and therapeutic interventions for multiple synaptic and memory dysfunctions associated with AD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19026746      PMCID: PMC2741400          DOI: 10.1016/j.nbd.2008.10.006

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  51 in total

1.  Time-dependent reorganization of brain circuitry underlying long-term memory storage.

Authors:  B Bontempi; C Laurent-Demir; C Destrade; R Jaffard
Journal:  Nature       Date:  1999-08-12       Impact factor: 49.962

2.  Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.

Authors:  Fabrizio Trinchese; Shumin Liu; Fortunato Battaglia; Sean Walter; Paul M Mathews; Ottavio Arancio
Journal:  Ann Neurol       Date:  2004-06       Impact factor: 10.422

Review 3.  Drug discovery in dementia: the role of rodent models.

Authors:  Debby Van Dam; Peter Paul De Deyn
Journal:  Nat Rev Drug Discov       Date:  2006-11       Impact factor: 84.694

Review 4.  The neuroscience of remote memory.

Authors:  Larry R Squire; Peter J Bayley
Journal:  Curr Opin Neurobiol       Date:  2007-03-02       Impact factor: 6.627

Review 5.  Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease.

Authors:  D T Kobayashi; K S Chen
Journal:  Genes Brain Behav       Date:  2005-04       Impact factor: 3.449

6.  Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice.

Authors:  J Larson; G Lynch; D Games; P Seubert
Journal:  Brain Res       Date:  1999-09-04       Impact factor: 3.252

7.  Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.

Authors:  Jorge J Palop; Jeannie Chin; Erik D Roberson; Jun Wang; Myo T Thwin; Nga Bien-Ly; Jong Yoo; Kaitlyn O Ho; Gui-Qiu Yu; Anatol Kreitzer; Steven Finkbeiner; Jeffrey L Noebels; Lennart Mucke
Journal:  Neuron       Date:  2007-09-06       Impact factor: 17.173

Review 8.  Memory deficits in Alzheimer's patients: a comprehensive review.

Authors:  G A Carlesimo; M Oscar-Berman
Journal:  Neuropsychol Rev       Date:  1992-06       Impact factor: 7.444

9.  Temporally graded retrograde amnesia of contextual fear after hippocampal damage in rats: within-subjects examination.

Authors:  S G Anagnostaras; S Maren; M S Fanselow
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

10.  Acquisition of conditioned taste aversion is impaired in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer's disease.

Authors:  P J Pistell; M Zhu; D K Ingram
Journal:  Neuroscience       Date:  2008-01-25       Impact factor: 3.590

View more
  122 in total

1.  5XFAD mice show early-onset gap encoding deficits in the auditory cortex.

Authors:  Aldis P Weible; Amanda J Stebritz; Michael Wehr
Journal:  Neurobiol Aging       Date:  2020-06-01       Impact factor: 4.673

2.  Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer's disease.

Authors:  Charles Y Shao; Suzanne S Mirra; Hameetha B R Sait; Todd C Sacktor; Einar M Sigurdsson
Journal:  Acta Neuropathol       Date:  2011-06-01       Impact factor: 17.088

Review 3.  Mouse models of Alzheimer's disease.

Authors:  Alicia M Hall; Erik D Roberson
Journal:  Brain Res Bull       Date:  2011-11-28       Impact factor: 4.077

4.  Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist.

Authors:  Pooneh Memar Ardestani; Andrew K Evans; Bitna Yi; Tiffany Nguyen; Laurence Coutellier; Mehrdad Shamloo
Journal:  Neuropharmacology       Date:  2017-01-13       Impact factor: 5.250

5.  Effects of BACE1 haploinsufficiency on APP processing and Aβ concentrations in male and female 5XFAD Alzheimer mice at different disease stages.

Authors:  L Devi; M Ohno
Journal:  Neuroscience       Date:  2015-08-24       Impact factor: 3.590

6.  7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer's disease.

Authors:  Zhentao Zhang; Xia Liu; Jason P Schroeder; Chi-Bun Chan; Mingke Song; Shan Ping Yu; David Weinshenker; Keqiang Ye
Journal:  Neuropsychopharmacology       Date:  2013-09-11       Impact factor: 7.853

7.  Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits.

Authors:  Dun-Sheng Yang; Philip Stavrides; Panaiyur S Mohan; Susmita Kaushik; Asok Kumar; Masuo Ohno; Stephen D Schmidt; Daniel Wesson; Urmi Bandyopadhyay; Ying Jiang; Monika Pawlik; Corrinne M Peterhoff; Austin J Yang; Donald A Wilson; Peter St George-Hyslop; David Westaway; Paul M Mathews; Efrat Levy; Ana M Cuervo; Ralph A Nixon
Journal:  Brain       Date:  2011-01       Impact factor: 13.501

8.  Flavonoid derivative 7,8-DHF attenuates TBI pathology via TrkB activation.

Authors:  Rahul Agrawal; Emily Noble; Ethika Tyagi; Yumei Zhuang; Zhe Ying; Fernando Gomez-Pinilla
Journal:  Biochim Biophys Acta       Date:  2015-02-03

Review 9.  Sphingolipid-Enriched Extracellular Vesicles and Alzheimer's Disease: A Decade of Research.

Authors:  Michael B Dinkins; Guanghu Wang; Erhard Bieberich
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

10.  Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice.

Authors:  Ryoichi Kimura; Latha Devi; Masuo Ohno
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.